Clinical trial
Combination Chemotherapy in Treating Patients With Recurrent Glioblastoma…
NCT00014105 · Atlantic Health System, Other · Unknown status
Key facts
| NCT number | NCT00014105 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Recurrent Glioblastoma Multiforme |
| Official title | Phase I/II Trial of Temozolomide and Carboplatin in Recurrent Glioblastoma Multiforme |
| Lead sponsor | Atlantic Health System, Other |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug |
| Interventions | carboplatin, temozolomide |
| Start date | Dec 1, 2000 |
| First posted | Feb 4, 2004 |
| Last update posted | Dec 4, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: